- Home
- OPP vs INMB Comparison
OPP vs INMB Comparison
Compare OPP & INMB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- OPP
- INMB
- Stock Information
- Founded
- OPP 2010
- INMB 2015
- Country
- OPP United States
- INMB United States
- Employees
- OPP N/A
- INMB N/A
- Industry
- OPP Finance/Investors Services
- INMB Biotechnology: Pharmaceutical Preparations
- Sector
- OPP Finance
- INMB Health Care
- Exchange
- OPP Nasdaq
- INMB Nasdaq
- Market Cap
- OPP 204.1M
- INMB 176.5M
- IPO Year
- OPP N/A
- INMB 2019
- Fundamental
- Price
- OPP $8.16
- INMB $7.84
- Analyst Decision
- OPP
- INMB Strong Buy
- Analyst Count
- OPP 0
- INMB 3
- Target Price
- OPP N/A
- INMB $24.33
- AVG Volume (30 Days)
- OPP 108.0K
- INMB 283.4K
- Earning Date
- OPP 01-01-0001
- INMB 05-08-2025
- Dividend Yield
- OPP 14.41%
- INMB N/A
- EPS Growth
- OPP N/A
- INMB N/A
- EPS
- OPP N/A
- INMB N/A
- Revenue
- OPP N/A
- INMB $14,000.00
- Revenue This Year
- OPP N/A
- INMB N/A
- Revenue Next Year
- OPP N/A
- INMB N/A
- P/E Ratio
- OPP N/A
- INMB N/A
- Revenue Growth
- OPP N/A
- INMB N/A
- 52 Week Low
- OPP $7.26
- INMB $4.32
- 52 Week High
- OPP $8.83
- INMB $12.72
- Technical
- Relative Strength Index (RSI)
- OPP 41.18
- INMB 52.47
- Support Level
- OPP $7.99
- INMB $6.98
- Resistance Level
- OPP $8.25
- INMB $7.51
- Average True Range (ATR)
- OPP 0.22
- INMB 0.72
- MACD
- OPP -0.01
- INMB 0.04
- Stochastic Oscillator
- OPP 32.27
- INMB 78.66
About OPP RiverNorth/DoubleLine Strategic Opportunity Fund Inc.
RiverNorth/DoubleLine Strategic Opportunity Fund Inc is a closed-end management investment company. The company's investment objective is to seek current income and overall total return.
About INMB INmune Bio Inc. Common stock
INmune Bio Inc is a clinical-stage biotechnology company. It is engaged in the development of new immunotherapies that reprogram a patient's innate immune system to allow immune system to fight cancer. The company's pipeline products includeINKmune, INBO3, XPro1595, LIVNate, and others.